Rare neurological diseases - a quest for new treatments
Canbex Therapeutics is dedicated to discovering new medicines for rare neurological diseases. Inspired by the call of patients and their families, our mission is to build on cutting-edge research by scientific pioneers to find effective new treatments for devastating disorders of the brain and nervous system.
Canbex has re-focused its programs and is developing collaborations with leading laboratories, scientists and physicians. Our model aims to provide preclinical and clinical proof of concept for new approaches to diseases where few if any treatment options are currently available.
The needs of patients and their families create a responsibility to make use of every available scientific advance. There is no guarantee of success, but not to act is a guarantee of failure.
Canbex Therapeutics Ltd
London BioScience Innovation Centre
2 Royal College Street
London NW1 0NH
Tel: +44(0)20 7554 5872